Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Terminated 3Active not recruiting 3Recruiting 2Unknown 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 11Leukemia, Myeloid, Acute 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Primary Myelofibrosis 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Thrombocythemia, Essential 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Polycythemia Vera 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1GATA2 Deficiency 1Esophageal Neoplasms 1Colorectal Neoplasms 1Castleman Disease 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neoplasm, Residual × Myeloid × Clear all
NCT03494569 2026-03-18

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

City of Hope Medical Center

Phase 1 Suspended
36 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡